News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Vitro Diagnostics (VODG) Announces Application of its Stem Cell Technology to Cancer Research & Treatment


1/13/2009 10:32:28 AM

GOLDEN, Colo.--(BUSINESS WIRE)--Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma, announced advances in its adult stem cell research indicating application of its technology and stem cell lines to cancer research and treatment. Cancer stem cells may generate solid tumors in various forms of cancer including those with poor prognosis including malignancies of the pancreas, lung and brain. Cancer stem cells may also be resistant to chemotherapy and radiation causing recurrences and metastasis of cancer following standard therapy. Additional research shows that other stem cells, including a type of adult stem cell known as mesenchymal stem cells (MSC) that Vitro is presently developing, migrate to cancer stem cells and may be used to carry toxic agents to selectively eradicate cancer stem cells thereby providing novel cellular therapy specifically targeted to cancer-causing cells.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES